| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0035-3787(06)75054-8 |
| P698 | PubMed publication ID | 16710126 |
| P2093 | author name string | Edan G | |
| Chaperon J | |||
| Sartori E | |||
| Belliard S | |||
| Chevrier C | |||
| Trebon P | |||
| P2860 | cites work | Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS) | Q22241644 |
| A rating scale for depression | Q24564540 | ||
| Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10 years | Q28191390 | ||
| Prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis | Q28249819 | ||
| Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study | Q28265388 | ||
| Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction | Q28276538 | ||
| The fractionation of working memory | Q30530729 | ||
| Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric, and MRI follow up study | Q33591681 | ||
| Attention related performance in two cognitively different subgroups of patients with multiple sclerosis | Q33734435 | ||
| Amantadine treatment of fatigue associated with multiple sclerosis | Q34047026 | ||
| Executive function in multiple sclerosis. The role of frontal lobe pathology | Q34064233 | ||
| New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
| Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire | Q35078171 | ||
| Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis | Q35455319 | ||
| Neuropsychological deficits in multiple sclerosis after acute relapse | Q36318073 | ||
| Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study | Q37261232 | ||
| Guidelines for neuropsychological research in multiple sclerosis | Q38137831 | ||
| Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis | Q38482163 | ||
| Cognitive loss in multiple sclerosis. Case reports and review of the literature | Q38602567 | ||
| Development of a multiple sclerosis functional composite as a clinical trial outcome measure | Q40810823 | ||
| A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments | Q42627062 | ||
| Metamemory and tested cognitive functioning in multiple sclerosis | Q43835918 | ||
| Paced auditory serial-addition task: a measure of recovery from concussion | Q43974735 | ||
| Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine | Q44575178 | ||
| Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationships | Q44730966 | ||
| Cognitive predictors of dementia in elderly community residents. | Q44913993 | ||
| Donepezil improved memory in multiple sclerosis in a randomized clinical trial | Q45144727 | ||
| Event-related brain potential evidence for a verbal working memory deficit in multiple sclerosis | Q48142757 | ||
| Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis | Q48162389 | ||
| Correlates of executive function in multiple sclerosis: the use of magnetic resonance spectroscopy as an index of focal pathology | Q48282605 | ||
| Acute optic neuritis. A cognitive and magnetic resonance imaging study | Q48424528 | ||
| Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis | Q48444625 | ||
| Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis | Q48557968 | ||
| Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy | Q48587027 | ||
| Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. | Q48665746 | ||
| Cognitive abnormalities in multiple sclerosis: a psychometric and MRI study | Q48798566 | ||
| Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b | Q48851809 | ||
| Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. | Q50875866 | ||
| Comparison of two brief neuropsychological batteries in people with multiple sclerosis. | Q51048665 | ||
| The ecological validity of clinical tests of memory and attention in multiple sclerosis. | Q51195833 | ||
| Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. | Q51960524 | ||
| Modulation of effective connectivity inside the working memory network in patients at the earliest stage of multiple sclerosis. | Q51981120 | ||
| [BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis] | Q52002522 | ||
| The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. | Q52003567 | ||
| Identifying multiple sclerosis patients with mild or global cognitive impairment using the Screening Examination for Cognitive Impairment (SEFCI). | Q52017301 | ||
| Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis. | Q52025126 | ||
| The nature of memory impairments in multiple sclerosis: acquisition versus retrieval. | Q52027430 | ||
| Working memory impairment among persons with chronic progressive multiple sclerosis. | Q52029763 | ||
| The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. | Q52049370 | ||
| Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. | Q52051437 | ||
| Memory impairment in multiple sclerosis. | Q52056662 | ||
| Influence of clinical variables on neuropsychological performance in multiple sclerosis. | Q52059739 | ||
| Automatic memory processes in patients with multiple sclerosis. | Q52095122 | ||
| Cognitive disturbances in patients with relapsing remitting multiple sclerosis. | Q52113272 | ||
| Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. A psychometric and MRI study. | Q52116426 | ||
| Anterograde and Retrograde Amnesia in Patients With Chronic Progressive Multiple Sclerosis | Q52123557 | ||
| Slowed information processing in multiple sclerosis. | Q52125126 | ||
| Depression in multiple sclerosis: relationship to working memory capacity. | Q52173907 | ||
| Cognitive impairment in patients with multiple sclerosis and mild physical disability. | Q52256834 | ||
| Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. | Q55039401 | ||
| Studies of interference in serial verbal reactions | Q55882047 | ||
| Neuropsychological effects of interferon ?-1a in relapsing multiple sclerosis | Q56972818 | ||
| Cortical lesions in multiple sclerosis | Q63185098 | ||
| Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning | Q67896534 | ||
| Fatigue in Multiple Sclerosis | Q68307338 | ||
| Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter? | Q68411792 | ||
| Cognitive function in recent-onset demyelinating diseases | Q69657433 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| Screening for cognitive dysfunction in multiple sclerosis | Q71658912 | ||
| Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up | Q72526361 | ||
| APOE and risk of cognitive impairment in multiple sclerosis | Q73120497 | ||
| Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR | Q74234831 | ||
| Depression in multiple sclerosis: relationship to planning ability | Q74564973 | ||
| Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning | Q78125864 | ||
| Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment | Q80332818 | ||
| P433 | issue | 5 | |
| P921 | main subject | neuropsychology | Q3872 |
| multiple sclerosis | Q8277 | ||
| psychometrics | Q506132 | ||
| P304 | page(s) | 603-615 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Revue neurologique | Q7318987 |
| P1476 | title | [From psychometry to neuropsychological disability in multiple sclerosis: a new brief French cognitive screening battery and cognitive risk factors] | |
| P478 | volume | 162 |
Search more.